Lista de obras -

10-year analysis of the ATAC trial: wrong conclusion? – Authors' reply

artículo científico publicado en 2011

A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies

artículo científico publicado en 2022

A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.

artículo científico publicado en 2014

About CD45-/CD31+/CD105+ circulating cells in patients with gynecologic malignancies--letter

artículo científico publicado en 2014

Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression.

artículo científico publicado en 2017

Amelioration of glucose control mobilizes circulating pericyte progenitor cells in type 2 diabetic patients with microangiopathy.

artículo científico publicado en 2012

Angiogenic cells, macroparticles and RNA transcripts in laparoscopic vs open surgery for colorectal cancer.

artículo científico publicado en 2010

Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer ⬇️

artículo científico publicado el 22 de agosto de 2011

Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells

artículo científico publicado en 2016

Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells

artículo científico publicado en 2004

CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma

scientific article published on 01 June 2002

Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma

artículo científico publicado en 2003

Circulating endothelial cell number and viability are reduced by exposure to high altitude.

artículo científico publicado en 2008

Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype

artículo científico publicado en 2008

Circulating endothelial cells and circulating endothelial progenitors.

artículo científico publicado en 2012

Circulating endothelial cells as a novel marker of angiogenesis

scientific article published on 01 January 2003

Circulating endothelial cells as biomarkers in clinical oncology

artículo científico publicado en 2010

Circulating endothelial cells. Biomarker of vascular disease

artículo científico publicado en 2005

Circulating endothelial progenitors are increased in Covid-19 patients and correlate with SARS-CoV-2 RNA in severe cases

scientific article published on 06 August 2020

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

artículo científico publicado en 2006

Circulating perivascular progenitors: a target of PDGFR inhibition.

artículo científico publicado en 2011

Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer.

artículo científico publicado en 2013

Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors.

artículo científico publicado en 2003

Cyclophosphamide and vinorelbine activate stem-like CD8+ T cells and improve anti-PD-1 efficacy in triple-negative breast cancer

scientific article published on 02 December 2020

Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia

scientific article published on 02 May 2020

Evaluation of circulating endothelial precursor cells in cancer patients

scientific article published on 01 January 2012

Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.

artículo científico publicado en 2008

If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.

artículo científico publicado en 2010

In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue

scientific article published on 01 August 2002

Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab ⬇️

artículo científico publicado el 16 de febrero de 2012

Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.

artículo científico publicado en 2009

Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

artículo científico publicado en 2003

Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.

artículo científico publicado en 2008

Molecular and cellular biomarkers for angiogenesis in clinical oncology

artículo científico publicado en 2007

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.

artículo científico publicado en 2009

Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan

artículo científico publicado en 2013

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

artículo científico publicado en 2008

Retracted: EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34+ Cell Differentiation and Increases Circulating Endothelial Precursors

artículo científico publicado en 2010

Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study

artículo científico publicado en 2010

Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents

artículo científico publicado en 2009

Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential ⬇️

artículo científico publicado el 1 de noviembre de 2012

Strategies to investigate circulating endothelial cells in cancer.

artículo científico publicado en 2003

Stroma cells: a novel target of herceptin activity

artículo científico publicado en 2003

Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies

artículo científico publicado en 2011

The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression ⬇️

artículo científico publicado el 3 de noviembre de 2011

The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells

artículo científico publicado en 2014

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

artículo científico publicado en 2006

The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer

scientific article published on 04 May 2009

Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.

artículo científico publicado en 2009

Viable circulating endothelial cells and their progenitors are increased in Covid-19 patients

artículo científico publicado en 2020

Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma.

artículo científico publicado en 2018

Lista de obras de

10-year analysis of the ATAC trial: wrong conclusion? – Authors' reply

A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies

A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.

About CD45-/CD31+/CD105+ circulating cells in patients with gynecologic malignancies--letter

Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression.

Amelioration of glucose control mobilizes circulating pericyte progenitor cells in type 2 diabetic patients with microangiopathy.

Angiogenic cells, macroparticles and RNA transcripts in laparoscopic vs open surgery for colorectal cancer.

Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer ⬇️

Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells

Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells

CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma

Chlorambucil in combination with induction and maintenance rituximab is feasible and active in indolent non-Hodgkin's lymphoma

Circulating endothelial cell number and viability are reduced by exposure to high altitude.

Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype

Circulating endothelial cells and circulating endothelial progenitors.

Circulating endothelial cells as a novel marker of angiogenesis

Circulating endothelial cells as biomarkers in clinical oncology

Circulating endothelial cells. Biomarker of vascular disease

Circulating endothelial progenitors are increased in Covid-19 patients and correlate with SARS-CoV-2 RNA in severe cases

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

Circulating perivascular progenitors: a target of PDGFR inhibition.

Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer.

Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors.

Cyclophosphamide and vinorelbine activate stem-like CD8+ T cells and improve anti-PD-1 efficacy in triple-negative breast cancer

Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia

Evaluation of circulating endothelial precursor cells in cancer patients

Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.

If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.

In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue

Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab ⬇️

Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.

Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.

Molecular and cellular biomarkers for angiogenesis in clinical oncology

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.

Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

Retracted: EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34+ Cell Differentiation and Increases Circulating Endothelial Precursors

Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study

Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents

Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential ⬇️

Strategies to investigate circulating endothelial cells in cancer.

Stroma cells: a novel target of herceptin activity

Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies

The White Adipose Tissue Used in Lipotransfer Procedures Is a Rich Reservoir of CD34+ Progenitors Able to Promote Cancer Progression ⬇️

The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer

Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.

Viable circulating endothelial cells and their progenitors are increased in Covid-19 patients

Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma.